Powered by

-Zydus successfully completes Phase II clinical trials with Pegylated Interferon alpha2b in India, the Company to start Phase III clinical trials

Nov 13, 2020 - ENP Newswire

Zydus Cadila, today announced that it has successfully completed a Phase 2 clinical trial in CoVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, 'PegiHepTM'.

In this open-label, randomized, comparator controlled study, involving 40 adult patients with moderate COVID-19 disease, 95% subjects in the test arm who received a single dose of PegiHepTM along with the Standard Of Care (SOC), became virus free as assessed by RT-PCR on day 14 and showed a statistically sign...